AI assistant
Sending…
Edesa Biotech, Inc. — Director's Dealing 2015
Nov 25, 2015
35006_dirs_2015-11-25_178373b9-0779-437b-9c6e-f81dad4493b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Stellar Biotechnologies, Inc. (SBOT)
CIK: 0001540159
Period of Report: 2015-11-24
Reporting Person: OAKES FRANK R. (Director, President, CEO & Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-24 | Common Shares, without par value | X | 150000 | $2.50 | Disposed | 193965 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-24 | Call Option (Obligation to Sell) | $2.50 | X | 150000 | Disposed | 2015-11-25 | Common Shares (150000) | Direct |
More from Edesa Biotech, Inc.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2